Updates in Clinical Management of Recurrent Urinary Tract Infections.

Area of Science:

• Urology
• Microbiology
• Women's Health

Background:

• Urinary tract infections (UTIs) represent a significant health burden for women, particularly recurrent cases.
• Current management often overemphasizes antibiotic eradication, potentially overlooking the role of the urogenital microbiome.
• The bladder microbiome and its interplay with the vaginal environment are critical factors in UTI susceptibility.

Purpose of the Study:

• To review evolving insights into the female urogenital microbiome for diagnosing, treating, and preventing recurrent UTIs in nonpregnant adult women.
• To highlight the limitations of traditional UTI care models and propose updated, microbiome-centered approaches.
• To discuss the specific challenges and interventions for postmenopausal women with recurrent UTIs.

Main Methods:

• Literature review and synthesis of current research on the female urogenital microbiome and recurrent UTIs.
• Analysis of traditional versus updated models of care for recurrent UTIs.
• Examination of evidence for microbiome-supportive interventions, including vaginal estrogen and supplements.

Main Results:

• The bladder harbors a complex microbiome influencing UTI susceptibility, interacting with the vaginal microbiome and local immune responses.
• Emphasis is shifting towards enhancing the protective microbiome, particularly in postmenopausal women experiencing microbiome shifts.
• Updated treatment strategies advocate for antimicrobial stewardship, diagnostic confirmation, and judicious antibiotic use.

Conclusions:

• A holistic, microbiome-centered approach is crucial for managing recurrent UTIs in women.
• Interventions like vaginal estrogen and microbiome support are key for prevention, especially in postmenopausal women.
• Future therapies like UTI vaccines and bacteriophage drugs may further reduce antibiotic reliance, necessitating individualized care plans.